Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to fall 87.28% to -43 cents per share on August 18

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q2'26

Est.

$-0.44

Q4'25

Missed

by $3.23

Q3'25

Missed

by $0.24

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.04

The last earnings report on March 26 showed earnings per share of -342 cents, missing the estimate of -18 cents. With 21.26K shares outstanding, the current market capitalization sits at 259.91M.

View a ticker or compare two or three

Compare

ARMP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ARMP